We've found
17,797
archived clinical trials in
Peripheral Vascular Disease
We've found
17,797
archived clinical trials in
Peripheral Vascular Disease
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Click here to add this to my saved trials
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Click here to add this to my saved trials
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Click here to add this to my saved trials
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Click here to add this to my saved trials
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Click here to add this to my saved trials
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Click here to add this to my saved trials
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Click here to add this to my saved trials
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Click here to add this to my saved trials
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Click here to add this to my saved trials
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Click here to add this to my saved trials
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Click here to add this to my saved trials
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Updated: 3/12/2016
A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Status: Enrolling
Updated: 3/12/2016
Click here to add this to my saved trials
Cardiac Remote Ischemic Preconditioning Before Elective Major Vascular Surgery
Updated: 3/14/2016
Cardiac Remote Ischemic Preconditioning Before Elective Major Vascular Surgery (CRIPES)
Status: Enrolling
Updated: 3/14/2016
Cardiac Remote Ischemic Preconditioning Before Elective Major Vascular Surgery
Updated: 3/14/2016
Cardiac Remote Ischemic Preconditioning Before Elective Major Vascular Surgery (CRIPES)
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
Effectiveness of Depression Treatment Following Coronary Artery Bypass Surgery
Updated: 3/14/2016
Treatment of Depression Following Bypass Surgery
Status: Enrolling
Updated: 3/14/2016
Effectiveness of Depression Treatment Following Coronary Artery Bypass Surgery
Updated: 3/14/2016
Treatment of Depression Following Bypass Surgery
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions
Updated: 3/14/2016
The Complete® SE SFA Study: The Medtronic Complete Self-Expanding SFA Stent System for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Proximal Popliteal Arteries
Status: Enrolling
Updated: 3/14/2016
The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions
Updated: 3/14/2016
The Complete® SE SFA Study: The Medtronic Complete Self-Expanding SFA Stent System for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Proximal Popliteal Arteries
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions
Updated: 3/14/2016
The Complete® SE SFA Study: The Medtronic Complete Self-Expanding SFA Stent System for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Proximal Popliteal Arteries
Status: Enrolling
Updated: 3/14/2016
The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions
Updated: 3/14/2016
The Complete® SE SFA Study: The Medtronic Complete Self-Expanding SFA Stent System for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Proximal Popliteal Arteries
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions
Updated: 3/14/2016
The Complete® SE SFA Study: The Medtronic Complete Self-Expanding SFA Stent System for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Proximal Popliteal Arteries
Status: Enrolling
Updated: 3/14/2016
The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions
Updated: 3/14/2016
The Complete® SE SFA Study: The Medtronic Complete Self-Expanding SFA Stent System for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Proximal Popliteal Arteries
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions
Updated: 3/14/2016
The Complete® SE SFA Study: The Medtronic Complete Self-Expanding SFA Stent System for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Proximal Popliteal Arteries
Status: Enrolling
Updated: 3/14/2016
The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions
Updated: 3/14/2016
The Complete® SE SFA Study: The Medtronic Complete Self-Expanding SFA Stent System for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Proximal Popliteal Arteries
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
Micro-Clinic Obesity and Metabolic Risk Prevention Program
Updated: 3/15/2016
Micro-Clinic Obesity and Metabolic Risk Prevention Program: A Randomized-Control Trial of a Social-Network Based Intervention
Status: Enrolling
Updated: 3/15/2016
Micro-Clinic Obesity and Metabolic Risk Prevention Program
Updated: 3/15/2016
Micro-Clinic Obesity and Metabolic Risk Prevention Program: A Randomized-Control Trial of a Social-Network Based Intervention
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
Efficacy of LCQ908 on Cardiovascular Risk
Updated: 3/16/2016
A Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy of LCQ908 on Cardiovascular Risk
Status: Enrolling
Updated: 3/16/2016
Efficacy of LCQ908 on Cardiovascular Risk
Updated: 3/16/2016
A Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy of LCQ908 on Cardiovascular Risk
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Walnut Consumption, Endothelial Function, and Biomarkers
Updated: 3/16/2016
Walnut Consumption, Endothelial Function, and Plasma Adipokines in Subjects With Diabetes or Coronary Disease: a Pilot Trial
Status: Enrolling
Updated: 3/16/2016
Walnut Consumption, Endothelial Function, and Biomarkers
Updated: 3/16/2016
Walnut Consumption, Endothelial Function, and Plasma Adipokines in Subjects With Diabetes or Coronary Disease: a Pilot Trial
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
The PCI Choice Trial: a Pilot Randomized Trial of a Decision Aid for Patients With Stable Coronary Artery Disease
Updated: 3/18/2016
The PCI Choice Trial: a Pilot Randomized Trial of a Decision Aid for Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 3/18/2016
The PCI Choice Trial: a Pilot Randomized Trial of a Decision Aid for Patients With Stable Coronary Artery Disease
Updated: 3/18/2016
The PCI Choice Trial: a Pilot Randomized Trial of a Decision Aid for Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Antithrombin III in Infants With Cardiopulmonary Bypass (CPB)
Updated: 3/21/2016
Antithrombin III Supplementation for Infants Undergoing Cardiac Surgery With Cardiopulmonary Bypass.
Status: Enrolling
Updated: 3/21/2016
Antithrombin III in Infants With Cardiopulmonary Bypass (CPB)
Updated: 3/21/2016
Antithrombin III Supplementation for Infants Undergoing Cardiac Surgery With Cardiopulmonary Bypass.
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
Study of the Cardiovascular Vitamin, CardioLife
Updated: 3/21/2016
Evaluation of the Metabolic and Physiological Profiles of Patients Diagnosed With Cardiovascular Disease (CVD) Following Administration of the Novel Cardiovascular Vitamin, CardioLife
Status: Enrolling
Updated: 3/21/2016
Study of the Cardiovascular Vitamin, CardioLife
Updated: 3/21/2016
Evaluation of the Metabolic and Physiological Profiles of Patients Diagnosed With Cardiovascular Disease (CVD) Following Administration of the Novel Cardiovascular Vitamin, CardioLife
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)
Updated: 3/21/2016
Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts
Status: Enrolling
Updated: 3/21/2016
The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)
Updated: 3/21/2016
Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)
Updated: 3/21/2016
Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts
Status: Enrolling
Updated: 3/21/2016
The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)
Updated: 3/21/2016
Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)
Updated: 3/21/2016
Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts
Status: Enrolling
Updated: 3/21/2016
The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)
Updated: 3/21/2016
Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)
Updated: 3/21/2016
Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts
Status: Enrolling
Updated: 3/21/2016
The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)
Updated: 3/21/2016
Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)
Updated: 3/23/2016
Pharmacogenomics of Anti-Platelet Interventions (The PAPI Study)
Status: Enrolling
Updated: 3/23/2016
Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)
Updated: 3/23/2016
Pharmacogenomics of Anti-Platelet Interventions (The PAPI Study)
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction
Updated: 3/24/2016
Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction
Status: Enrolling
Updated: 3/24/2016
Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction
Updated: 3/24/2016
Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction
Status: Enrolling
Updated: 3/24/2016
Click here to add this to my saved trials
Exercise Stress CMR Comparison Study
Updated: 3/28/2016
Comparison of Exercise MRI and Exercise Nuclear Scintigraphy in Patients With Suspected Coronary Artery Disease.
Status: Enrolling
Updated: 3/28/2016
Exercise Stress CMR Comparison Study
Updated: 3/28/2016
Comparison of Exercise MRI and Exercise Nuclear Scintigraphy in Patients With Suspected Coronary Artery Disease.
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
Effect of Soy on HDL-C Function, Central Blood Pressure, and Arterial Stiffness
Updated: 3/28/2016
Effect of Soy on HDL-C Function, Central Blood Pressure, and Arterial Stiffness
Status: Enrolling
Updated: 3/28/2016
Effect of Soy on HDL-C Function, Central Blood Pressure, and Arterial Stiffness
Updated: 3/28/2016
Effect of Soy on HDL-C Function, Central Blood Pressure, and Arterial Stiffness
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
Cerebral Oximetric Monitoring of the Posterior Circulation
Updated: 3/28/2016
Cerebral Oximetric Monitoring of the Posterior Circulation in Neonates and Infants During Complex Aortic Arch Reconstruction.
Status: Enrolling
Updated: 3/28/2016
Cerebral Oximetric Monitoring of the Posterior Circulation
Updated: 3/28/2016
Cerebral Oximetric Monitoring of the Posterior Circulation in Neonates and Infants During Complex Aortic Arch Reconstruction.
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation
Updated: 3/29/2016
The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation
Status: Enrolling
Updated: 3/29/2016
The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation
Updated: 3/29/2016
The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation
Status: Enrolling
Updated: 3/29/2016
Click here to add this to my saved trials
A Safety Study of ABI-007 for In-Stent Restenosis
Updated: 3/30/2016
A Phase II Safety Study of Systemic Nanoparticle Paclitaxel (ABI-007)for In-Stent Restenosis
Status: Enrolling
Updated: 3/30/2016
A Safety Study of ABI-007 for In-Stent Restenosis
Updated: 3/30/2016
A Phase II Safety Study of Systemic Nanoparticle Paclitaxel (ABI-007)for In-Stent Restenosis
Status: Enrolling
Updated: 3/30/2016
Click here to add this to my saved trials
Pilot Study of Home Blood Pressure Control Program (eBP Control)
Updated: 3/31/2016
Pilot Study of Home Blood Pressure Control Program (eBP Control)
Status: Enrolling
Updated: 3/31/2016
Pilot Study of Home Blood Pressure Control Program (eBP Control)
Updated: 3/31/2016
Pilot Study of Home Blood Pressure Control Program (eBP Control)
Status: Enrolling
Updated: 3/31/2016
Click here to add this to my saved trials
Self-management and Cognitive Function in Adults With Heart Failure
Updated: 4/6/2016
Cognitive Impairment and Self-management in Adults With Heart Failure
Status: Enrolling
Updated: 4/6/2016
Self-management and Cognitive Function in Adults With Heart Failure
Updated: 4/6/2016
Cognitive Impairment and Self-management in Adults With Heart Failure
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Updated: 4/6/2016
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials